FDA setback
Rocheās subcutaneous Tecentriq faces FDA setback due to manufacturing updates
Anika Sharma
Roche may experience a delay in the FDA decision for its subcutaneous version of the cancer immunotherapy Tecentriq, as it ...
Astrazeneca Suffers Setback As FDA Rejects Ultomiris For Rare Autoimmune Disease
Anika Sharma
AstraZeneca’s plans to expand the use of Ultomiris in the United States have encountered a setback, as the FDA issued ...
